Table 1 Primer sequences
From: Genetic polymorphisms of patients on stable warfarin maintenance therapy in a Ghanaian population
| Sequences | Amplicon size | Restriction enzyme | Reference | |
|---|---|---|---|---|
| CYP2C9*2 | ||||
| Forward | 5′-CACTGGCTGAAAGAGCTAACAGAG-3′ | 375 bp | AvaII | [22] |
| Reverse | 5′-GTGATATGGAGTAGGGTCACCCAC-3′ | |||
| CYP2C9*3 | ||||
| Forward | 5′-TGCACGAGGTCCAGAGGTAC-3′ | 105 bp | KpnI | [22] |
| Reverse | 5′-ACAAACTTACCTTGGGAATGAGA-3′ | |||
| CYP4F2 | ||||
| Forward | 5′-CGGAACTTGGACCATCTACA-3′ | 439 bp | PvuII | [14] |
| Reverse | 5′-CCTACTCTCCCACAGGCATTA-3′ | |||
| VKORC1 | ||||
| Forward | 5′-ATCCCTCTGGGAAGTCAAGC-3′ | 636 bp | NciI | [23] |
| Reverse | 5′-CACCTTCAACCTCTCCATCC-3′ | |||
